Skip to content

Retrospective multicenter clinical trail of concurrent chemoradiotherapy for advanced cervical cancer

Retrospective multicenter clinical trail of concurrent chemoradiotherapy for advanced cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRC-17010868
Enrollment
Unknown
Registered
2017-03-14
Start date
2017-03-12
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Case series:Nil

Sponsors

Radiotherapy department of Peking Union Medical College Hospital, Chinese Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Female aged 18 to 70 years old; 2) KPS=60; 3) cervical cancer confirmed by pathology; 4) FIGO stage was advanced cervical cancer(IB2 to IVA); 5) first treatment;

Exclusion criteria

Exclusion criteria: 1) recurrent or non-first treatment; 2) combined with other malignancies except skin cancer; 3) other serious diseases; 4) uterine tube and ovoid tube implanted individually or only uterine tube implanted durying brachytheray; 5) follow-up loss; 6) data missing or incomplete.

Design outcomes

Primary

MeasureTime frame
OS;DFS;prognosis factor;

Secondary

MeasureTime frame
actue toxicity rate;chronic toxicity rate;

Countries

China

Contacts

Public ContactZhang Fuquan

Radiotherapy department of Peking Union Medical College Hospital, Chinese Academy of Sciences

zhangfuquan3@sina.com+86 010-69155482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026